![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CA4 |
Gene summary for CA4 |
![]() |
Gene information | Species | Human | Gene symbol | CA4 | Gene ID | 762 |
Gene name | carbonic anhydrase 4 | |
Gene Alias | CAIV | |
Cytomap | 17q23.1 | |
Gene Type | protein-coding | GO ID | GO:0006730 | UniProtAcc | P22748 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
762 | CA4 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.65e-04 | -1.99e-01 | 0.0155 |
762 | CA4 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.27e-03 | 1.09e+00 | -0.1954 |
762 | CA4 | HTA11_411_2000001011 | Human | Colorectum | SER | 1.94e-06 | 1.89e+00 | -0.2602 |
762 | CA4 | HTA11_2112_2000001011 | Human | Colorectum | SER | 1.87e-04 | 2.20e+00 | -0.2196 |
762 | CA4 | HTA11_3361_2000001011 | Human | Colorectum | AD | 9.73e-05 | 1.12e+00 | -0.1207 |
762 | CA4 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.06e-03 | 6.08e-01 | -0.1464 |
762 | CA4 | HTA11_5212_2000001011 | Human | Colorectum | AD | 8.11e-05 | 1.72e+00 | -0.2061 |
762 | CA4 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.16e-03 | -1.99e-01 | 0.096 |
762 | CA4 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.71e-02 | -1.90e-01 | 0.0674 |
762 | CA4 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.85e-03 | -1.95e-01 | 0.3859 |
762 | CA4 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 4.07e-04 | -1.99e-01 | 0.3005 |
762 | CA4 | A002-C-010 | Human | Colorectum | FAP | 3.11e-03 | -1.95e-01 | 0.242 |
762 | CA4 | A002-C-201 | Human | Colorectum | FAP | 3.18e-03 | -1.86e-01 | 0.0324 |
762 | CA4 | A001-C-119 | Human | Colorectum | FAP | 3.29e-02 | -1.99e-01 | -0.1557 |
762 | CA4 | A002-C-205 | Human | Colorectum | FAP | 3.25e-05 | -1.99e-01 | -0.1236 |
762 | CA4 | A015-C-006 | Human | Colorectum | FAP | 1.01e-02 | -1.99e-01 | -0.0994 |
762 | CA4 | A015-C-202 | Human | Colorectum | FAP | 3.32e-02 | -1.86e-01 | -0.0849 |
762 | CA4 | A002-C-016 | Human | Colorectum | FAP | 9.04e-05 | -1.95e-01 | 0.0521 |
762 | CA4 | A002-C-116 | Human | Colorectum | FAP | 4.07e-04 | -1.99e-01 | -0.0452 |
762 | CA4 | F072B | Human | Colorectum | FAP | 4.07e-04 | -1.99e-01 | 0.257 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:007089712 | Thyroid | ATC | transcription preinitiation complex assembly | 22/6293 | 36/18723 | 6.58e-04 | 3.73e-03 | 22 |
GO:000633715 | Thyroid | ATC | nucleosome disassembly | 13/6293 | 18/18723 | 9.27e-04 | 4.98e-03 | 13 |
GO:003149813 | Thyroid | ATC | chromatin disassembly | 14/6293 | 20/18723 | 9.60e-04 | 5.13e-03 | 14 |
GO:005109122 | Thyroid | ATC | positive regulation of DNA-binding transcription factor activity | 111/6293 | 260/18723 | 1.32e-03 | 6.88e-03 | 111 |
GO:000633813 | Thyroid | ATC | chromatin remodeling | 109/6293 | 255/18723 | 1.38e-03 | 7.15e-03 | 109 |
GO:004809621 | Thyroid | ATC | chromatin-mediated maintenance of transcription | 9/6293 | 11/18723 | 1.46e-03 | 7.47e-03 | 9 |
GO:000974632 | Thyroid | ATC | response to hexose | 95/6293 | 219/18723 | 1.56e-03 | 7.92e-03 | 95 |
GO:000974932 | Thyroid | ATC | response to glucose | 92/6293 | 212/18723 | 1.80e-03 | 8.87e-03 | 92 |
GO:00718242 | Thyroid | ATC | protein-DNA complex subunit organization | 103/6293 | 241/18723 | 1.84e-03 | 9.03e-03 | 103 |
GO:000635611 | Thyroid | ATC | regulation of transcription by RNA polymerase I | 20/6293 | 34/18723 | 2.22e-03 | 1.04e-02 | 20 |
GO:0009755110 | Thyroid | ATC | hormone-mediated signaling pathway | 83/6293 | 190/18723 | 2.34e-03 | 1.09e-02 | 83 |
GO:003350024 | Thyroid | ATC | carbohydrate homeostasis | 109/6293 | 259/18723 | 2.56e-03 | 1.18e-02 | 109 |
GO:005170222 | Thyroid | ATC | biological process involved in interaction with symbiont | 45/6293 | 94/18723 | 2.86e-03 | 1.30e-02 | 45 |
GO:00607657 | Thyroid | ATC | regulation of androgen receptor signaling pathway | 17/6293 | 28/18723 | 2.97e-03 | 1.35e-02 | 17 |
GO:007132224 | Thyroid | ATC | cellular response to carbohydrate stimulus | 72/6293 | 163/18723 | 3.12e-03 | 1.41e-02 | 72 |
GO:004259325 | Thyroid | ATC | glucose homeostasis | 108/6293 | 258/18723 | 3.27e-03 | 1.47e-02 | 108 |
GO:000167825 | Thyroid | ATC | cellular glucose homeostasis | 75/6293 | 172/18723 | 3.89e-03 | 1.69e-02 | 75 |
GO:004392313 | Thyroid | ATC | positive regulation by host of viral transcription | 11/6293 | 16/18723 | 4.33e-03 | 1.80e-02 | 11 |
GO:000636011 | Thyroid | ATC | transcription by RNA polymerase I | 28/6293 | 55/18723 | 5.94e-03 | 2.39e-02 | 28 |
GO:007133324 | Thyroid | ATC | cellular response to glucose stimulus | 66/6293 | 151/18723 | 6.05e-03 | 2.43e-02 | 66 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04964 | Colorectum | AD | Proximal tubule bicarbonate reclamation | 11/2092 | 23/8465 | 1.35e-02 | 4.86e-02 | 3.10e-02 | 11 |
hsa049641 | Colorectum | AD | Proximal tubule bicarbonate reclamation | 11/2092 | 23/8465 | 1.35e-02 | 4.86e-02 | 3.10e-02 | 11 |
hsa049642 | Colorectum | SER | Proximal tubule bicarbonate reclamation | 10/1580 | 23/8465 | 5.33e-03 | 3.28e-02 | 2.38e-02 | 10 |
hsa049643 | Colorectum | SER | Proximal tubule bicarbonate reclamation | 10/1580 | 23/8465 | 5.33e-03 | 3.28e-02 | 2.38e-02 | 10 |
hsa049644 | Colorectum | CRC | Proximal tubule bicarbonate reclamation | 8/1091 | 23/8465 | 6.09e-03 | 3.04e-02 | 2.06e-02 | 8 |
hsa049645 | Colorectum | CRC | Proximal tubule bicarbonate reclamation | 8/1091 | 23/8465 | 6.09e-03 | 3.04e-02 | 2.06e-02 | 8 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CA4 | SNV | Missense_Mutation | rs121434552 | c.206N>A | p.Arg69His | p.R69H | P22748 | protein_coding | deleterious(0.05) | benign(0) | TCGA-AQ-A04H-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD |
CA4 | SNV | Missense_Mutation | c.238A>T | p.Thr80Ser | p.T80S | P22748 | protein_coding | tolerated(0.85) | benign(0.001) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CA4 | SNV | Missense_Mutation | rs766918079 | c.680N>T | p.Pro227Leu | p.P227L | P22748 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-E2-A576-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | taxotere | SD |
CA4 | SNV | Missense_Mutation | c.197N>C | p.Lys66Thr | p.K66T | P22748 | protein_coding | tolerated(0.06) | benign(0.081) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
CA4 | SNV | Missense_Mutation | novel | c.139C>G | p.Gln47Glu | p.Q47E | P22748 | protein_coding | tolerated(0.06) | possibly_damaging(0.483) | TCGA-VS-A8QM-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
CA4 | SNV | Missense_Mutation | rs769858478 | c.656N>A | p.Arg219His | p.R219H | P22748 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-ZJ-AB0H-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |
CA4 | SNV | Missense_Mutation | c.346C>A | p.Leu116Met | p.L116M | P22748 | protein_coding | deleterious(0.01) | probably_damaging(0.993) | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
CA4 | SNV | Missense_Mutation | rs373844529 | c.358G>A | p.Asp120Asn | p.D120N | P22748 | protein_coding | tolerated(0.61) | benign(0) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
CA4 | SNV | Missense_Mutation | rs200180434 | c.205N>T | p.Arg69Cys | p.R69C | P22748 | protein_coding | deleterious(0) | possibly_damaging(0.724) | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
CA4 | SNV | Missense_Mutation | novel | c.88N>A | p.Glu30Lys | p.E30K | P22748 | protein_coding | tolerated(1) | benign(0) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | Salicyclic acid | |||
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | inhibitor | 385612193 | ||
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | inhibitor | CHEMBL19 | METHAZOLAMIDE | |
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | inhibitor | 385612194 | ||
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | inhibitor | CHEMBL18 | ETHOXZOLAMIDE | |
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | CHLOROTHIAZIDE | CHLOROTHIAZIDE | ||
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | Brinzolamide | BRINZOLAMIDE | ||
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | inhibitor | CHEMBL220492 | TOPIRAMATE | |
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | TRICHLORMETHIAZIDE | TRICHLORMETHIAZIDE | ||
762 | CA4 | DRUGGABLE GENOME, ENZYME, TRANSPORTER, CELL SURFACE | FERULIC ACID |
Page: 1 2 3 |